Schoevers, RA, Beekman, AT, Deeg, DJ, Jonker, C, van Tilburg, W. Comorbidity and risk-patterns of depression, generalised anxiety disorder and mixed anxiety-depression in later life: results from the AMSTEL study. Int J Geriat Psychiatry
2003; 18: 994–1001.
Beekman, AT, Bremmer, MA, Deeg, DJ, van Balkom, AJ, Smit, JH, de Beurs, E, van Dyck, R, van Tilburg, W. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriat Psychiatry
1998; 13: 717–26.
Blazer, D, George, LK, Hughes, D. The epidemiology of anxiety disorders: an age comparison. In Anxiety in the Elderly: Treatment and Research (ed Salzman, C., Lebowitz, B. D.): 17–30. Springer, 1991.
de Beurs, E, Beekman, AT, van Balkom, AJ, Deeg, DJ, van Dyck, R, van Tilburg, W. Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med
1999; 29: 583–93.
Kessler, RC, Zhao, S, Katz, SJ, Kouzis, AC, Frank, RG, Edlund, M, Leaf, P. Past-year use of outpatient services for psychiatric problems in the National Comorbidity Survey. Am J Psychiatry
1999; 156: 115–23.
Kessler, RC, Andrade, LH, Bijl, RV, Offord, DR, Demler, OV, Stein, DJ. The effects of co-morbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. International Consortium in Psychiatric Epidemiology. Psychol Med
2002; 32: 1213–25.
Lieb, R, Becker, E, Altamura, C. The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol
2005; 15: 445–52.
Beekman, AT, de Beurs, E, van Balkom, AJ, Deeg, DJ, van Dyck, R, van Tilburg, W. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry
2000; 157: 89–95.
Bruce, SE, Yonkers, KA, Otto, MW, Eisen, JL, Weisberg, RB, Pagano, M, Shea, MT, Keller, MB. Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry
2005; 162: 1179–87.
Schuurmans, J, Comijs, HC, Beekman, AT, de Beurs, E, Deeg, DJ, Emmelkamp, PM, van Dyck, R. The outcome of anxiety disorders in older people at 6-year follow-up: results from the Longitudinal Aging Study Amsterdam. Acta Psychiatr Scand
2005; 111: 420–8.
Flint, AJ. Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging
2005; 22: 101–14.
Lenze, EJ, Mulsant, BH, Shear, MK, Dew, MA, Miller, MD, Pollock, BG, Houck, P, Tracey, B, Reynolds, CF 3rd.
Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry
2005; 162: 146–50.
Katz, IR, Reynolds, CF 3rd, Alexopoulos, GS, Hackett, D. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Amer Geriat Soc
2002; 50: 18–25.
Madhusoodanan, S, Bogunovic, OJ. Safety of benzodiazepines in the geriatric population. Expert Opin Drug Safe
2004; 3: 485–93.
Montgomery, SA, Tobias, K, Zornberg, GL, Kasper, S, Pande, AC. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine. J Clin Psychiatry
2006; 67: 771–82.
Rickels, K, Pollack, MH, Feltner, DE, Lydiard, RB, Zimbroff, DL, Bielski, RJ, Tobias, K, Brock, JD, Zornberg, GL, Pande, AC. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry
2005; 62: 1022–30.
Pohl, RB, Feltner, DE, Fieve, RR, Pande, AC. Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosing. J Clin Psychopharm
2005; 25: 151–8.
Feltner, DE, Crockatt, JG, Dubovsky, SJ, Cohn, CK, Shrivastava, RK, Targum, SD, Liu-Dumaw, M, Carter, CM, Pande, AC. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharm
2003; 23: 240–9.
International Conference on Harmonisation. Guidance for Industry. E6 Good Clinical Practice: Consolidated Guidance. US Food and Drug Administration, 1996 (http://www.fda.gov/cder/guidance/959fnl.pdf).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV).
APA Press, 1994.
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R, Dunbar, GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry
1998; 59 (suppl 20): 22–33.
Sheehan, DV, Lecrubier, Y, Sheehan, KH, Amorim, P, Janavs, J, Weiller, E, Hergueta, T, Baker, R, Dunbar, GC. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID P and its reliability. Eur Psychiatry
1997; 12: 232–41.
Hamilton, M. The assessment of anxiety states by rating. Br J Med Psychol
1959; 32: 10.
Bech, JG, Stanley, MA, Zebb, BJ. Effectiveness of the Hamilton Anxiety Rating Scale with older Generalized Anxiety Disorder patients. J Clin Geropsychol
1999; 5: 281–90.
Hamilton, M A. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Guy, W. ECDEU Assessment Manual for Psychopharmacology.
US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, 1976.
Bech, P, Allerup, P, Maier, W, Albus, M, Lavori, P, Ayuso, JL. The Hamilton scales and the Hopkins Symptom Checklist (SCL–90). A cross-national validity study in patients with panic disorders. Br J Psychiatry
1992; 160: 206–11.
Neter, J, Wasserman, W, Kutner, MH. Applied Linear Statistical Models.
Hosmer, DW, Lemeshow, L. Applied Logistic Regression. John Wiley & Sons, 1989.
Stokes, ME, Davis, CS, Koch, GG. Categorical Data Analysis Using the SAS System. SAS Institute Inc, 1995.
Stein, DJ, Andersen, HF, Goodman, WK. Escitalopram for the treatment of generalised anxiety disorder: efficacy across different subgroups and outcomes. Ann Clin Psychiatry
2005; 17: 71–5.
Thase, ME. Treatment of anxiety disorders with venlafaxine XR. Expert Rev Neurother
2006; 6: 269–82.